No abstract available.
Hyperlipidemias*

No abstract available.
Hyperlipidemias*

No abstract available.
Hyperlipidemias*

No abstract available.
Hyperlipidemias* ; Korea*

51 hypertension patients with lipidemia disorder were treated at Hospital of Military Traditional Medicine from April to September 2004. All patients were divided into 2 groups: The control group consisted of 19 patients who received Caropil 25mg tablet/ twice a day during 28 continuous days; the study group consisted of 32 patients who received a traditional recipe of TT2/per day divided into 2 times every 12 hours during 28 days. Among hypertension patients with primary lipidemia disorder and signs of phlegm wetness or and phlegm heat types, using a traditional recipe of T22/per day during continuous 28 days had effects of regulating the index of lipidemia: CT decrease of 14.9%; TG decrease of 27.5%; LDL-C decrease of 16.2%; the effects of increasing HDL-C were not significantly (increase of 6.5%).
Hypertension ; Hyperlipidemias

No abstract available.
Hyperlipidemias* ; Hypertension* ; Mass Screening*

After pantethine in doses of 540 mg per day was administered for 8 weeks in 20 patients with hyperlipidemia, the serum levels of total cholesterol, triglyceride and HDL-cholesterol were compared with the pretreatment level. The serum level of total cholesterol decreased to 240+/-52 mg%[mean+/-standard deviation] after 4 weeks and 223+/-41 mg% after 8 weeks from the pretreatment level of 293+/-38 mg%(p<0.01). The serum triglyceride level also decreased to 254+/-109 mg% after 4 weeks and 239+/-114 mg% after 8 weeks from the pretreatment level of 375+/-126 mg%(p<0.01). But, there was no significant change in the serum levels of HDL-cholesterol before and after treatment (56+/-27 mg% beforAfter pantethine in doses of 540 mg per day was administered for 8 weeks in 20 patients with hyperlipidemia, the serum levels of total cholesterol, triglyceride and HDL-cholesterol were compared with the pretreatment level. The serum level of total cholesterol decreased to 240+/-52 mg%[mean+/-standard deviation] after 4 weeks and 223+/-41 mg% after 8 weeks from the pretreatment level of 293+/-38 mg%(p<0.01). The serum triglyceride level also decreased to 254+/-109 mg% after 4 weeks and 239+/-114 mg% after 8 weeks from the pretreatment level of 375+/-126 mg%(p<0.01). But, there was no significant change in the serum levels of HDL-cholesterol before and after treatment (56+/-27 mg% before treatment, 56+/-18 mg% after 4 weeks and 59+/-22 mg% after 8 weeks). Pantethine was well tolerated in most patients.
Cholesterol ; Humans ; Hyperlipidemias* ; Triglycerides

No abstract available.
Calcineurin ; Diabetes Mellitus ; Hyperlipidemias

No abstract available.
Child* ; Humans ; Hyperlipidemias*

No abstract available.
Hyperlipidemias* ; Kidney* ; Transplantation*